Quercetin inhibits α3β4 nicotinic acetylcholine receptor-mediated ion currents expressed in Xenopus oocytes

Korean Journal of Physiology and Pharmacology

Volumn 15, Issue 1, 2011, Pages 17-22

  Lee, Byung Hwan ^a   Hwang, Sung Hee ^a   Choi, Sun Hye ^a   Shin, Tae Joon ^a   Kang, Jiyeon ^a   Lee, Sang Mok ^a   Nah, Seung Yeol ^a  

^a Konkuk University   (South Korea)

Author keywords

3 4 nicotinic acetylcholine receptor; Flavonoids; Quercetin; Xenopus oocyte

Indexed keywords

ACETYLCHOLINE; COMPLEMENTARY RNA; ION CHANNEL; NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA3BETA4; NICOTINIC RECEPTOR; QUERCETIN; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DRUG EFFECT; DRUG MECHANISM; IC 50; ION CURRENT; NONHUMAN; OOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; XENOPUS;

EID: 79953115762     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: 10.4196/kjpp.2011.15.1.17     Document Type: Article

References (35)

1. Jensen ML, Schousboe A, Ahring PK. Charge selectivity of the Cys-loop family of ligand-gated ion channels. J Neurochem. 2005;92:217-225. (Pubitemid 40194013)
2. Dani JA, Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol. 2007;47:699-729.
3. Boulter J, Evans K, Goldman D, Martin G, Treco D, Heinemann S, Patrick J. Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor alpha-subunit. Nature. 1986;319:368-374. (Pubitemid 16163895)
4. Boulter J, Connolly J, Deneris E, Goldman D, Heinemann S, Patrick J. Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family. Proc Natl Acad Sci U S A. 1987;84:7763-7767.
5. Karlin A. Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci. 2002;3:102-114. (Pubitemid 135706579)
6. Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol. 2004;74:363-396. (Pubitemid 40092737)
7. Boorman JP, Groot-Kormelink PJ, Sivilotti LG. Stoichiometry of human recombinant neuronal nicotinic receptors containing the b3 subunit expressed in Xenopus oocytes. J Physiol. 2000; 529:565-577. (Pubitemid 32051062)
8. Free RB, McKay SB, Boyd RT, McKay DB. Evidence for constitutive expression of bovine adrenal a3beta4* nicotinic acetylcholine receptors. Ann N Y Acad Sci. 2002;971:145-147. (Pubitemid 35305280)
9. Di Angelantonio S, Matteoni C, Fabbretti E, Nistri A. Molecular biology and electrophysiology of neuronal nicotinic receptors of rat chromaffin cells. Eur J Neurosci. 2003;17:2313-2322. (Pubitemid 36793740)
10. Campos-Caro A, Smillie FI, Domínguez del Toro E, Rovira JC, Vicente-Agulló F, Chapuli J, Juíz JM, Sala S, Sala F, Ballesta JJ, Criado M. Neuronal nicotinic acetylcholine receptors on bovine chromaffin cells: cloning, expression, and genomic organization of receptor subunits. J Neurochem. 1997;68:488-497.
11. Havsteen BH. The biochemistry and medical significance of the flavonoids. Pharmacol Ther. 2002;96:67-202.
12. Speroni E, Minghetti A. Neuropharmacological activity of extracts from Passiflora incarnate. Planta Med. 1988;54:488-491.
13. Picq M, Cheav SL, Prigent AF. Effect of two flavonoid compounds on central nervous system. Analgesic activity. Life Sci. 1991;49:1979-1988.
14. Kandaswami C, Middleton E Jr. Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Biol. 1994;366:351-376.
15. Oyama Y, Fuchs PA, Katayama N, Noda K. Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2 +)-loaded brain neurons. Brain Res. 1994;635:125-129.
16. Harborne JB, Williams CA. Advances in flavonoid research since 1992. Phytochemistry. 2000;55:481-504.
17. Lee BH, Jeong SM, Lee JH, Kim JH, Yoon IS, Lee JH, Choi SH, Lee SM, Chang CG, Kim HC, Han Y, Paik HD, Kim Y, Nah SY. Quercetin inhibits the 5-hydroxytryptamine type 3 receptor-mediated ion current by interacting with pre-transmembrane domain I. Mol Cells. 2005;20:69-73.
18. Lee BH, Lee JH, Yoon IS, Lee JH, Choi SH, Pyo MK, Jeong SM, Choi WS, Shin TJ, Lee SM, Rhim H, Park YS, Han YS, Paik HD, Cho SG, Kim CH, Lim YH, Nah SY. Human glycine alpha1 receptor inhibition by quercetin is abolished or inversed by alpha267 mutations in transmembrane domain 2. Brain Res. 2007;1161:1-10. (Pubitemid 47068423)
19. 2+ binding sites. Mol Cells. 2010;30:245-253.
20. Lee BH, Choi SH, Shin TJ, Pyo MK, Hwang SH, Lee SM, Paik HD, Kim HC, Nah SY. Effects of quercetin on α9α10 nicotinic acetylcholine receptor-mediated ion currents. Eur J Pharmacol. 2011;650:79-85.
21. Sine SM, Taylor P. Local anesthetics and histrionicotoxin are allosteric inhibitors of the acetylcholine receptor. Studies of clonal muscle cells. J Biol Chem. 1982;257:8106-8114. (Pubitemid 13241228)
22. Heidmann T, Oswald RE, Changeux JP. Multiple sites of action for noncompetitive blockers on acetylcholine receptor rich membrane fragments from torpedo marmorata. Biochemistry. 1983;22:3112-3127. (Pubitemid 13061673)
23. Arias HR. Luminal and non-luminal non-competitive inhibitor binding sites on the nicotinic acetylcholine receptor. Mol Membr Biol. 1996;13:1-17.
24. Grønlien JH, Ween H, Thorin-Hagene K, Cassar S, Li J, Briggs CA, Gopalakrishnan M, Malysz J. Importance of M2-M3 loop in governing properties of genistein at the α7 nicotinic acetylcholine receptor inferred from α 7/5-HT3A chimera. Eur J Pharmacol. 2010;647:37-47.
25. Zhang H, Toyohira Y, Ueno S, Shinohara Y, Itoh H, Furuno Y, Yamakuni T, Tsutsui M, Takahashi K, Yanagihara N. Dual effects of nobiletin, a citrus polymethoxy flavone, on catecholamine secretion in cultured bovine adrenal medullary cells. J Neurochem. 2010;114:1030-1038.
26. Shinohara Y, Toyohira Y, Ueno S, Liu M, Tsutsui M, Yanagihara N. Effects of resveratrol, a grape polyphenol, on catecholamine secretion and synthesis in cultured bovine adrenal medullary cells. Biochem Pharmacol. 2007;74:1608-1618.
27. Yu BS, Na DM, Kang MY, Lim DY. Polyphenols of Rubus coreanum inhibit catecholamine secretion from the perfused adrenal medulla of SHRs. Korean J Physiol Pharmacol. 2009; 13:517-526.
28. Garcia-Colunga J, Miledi R. Effects of serotonergic agents on neuronal nicotinic acetylcholine receptors. Proc Natl Acad Sci U S A. 1995;92:2919-2923.
29. Garcia-Colunga J, Miledi R. Modulation of nicotinic acetylcholine receptors by strychnine. Proc Natl Acad Sci U S A. 1999;96:4113-4118. (Pubitemid 29169045)
30. Herrero CJ, García-Palomero E, Pintado AJ, García AG, Montiel C. Differential blockade of rat alpha3beta4 and alpha 7 neuronal nicotinic receptors by omega-conotoxin MVHC, omega-conotoxin GVIA and diltiazem. Br J Pharmacol. 1999; 127:1375-1387. (Pubitemid 29358938)
31. Haghighi AP, Cooper E. A molecular link between inward rectification and calcium permeability of neuronal nicotinic acetylcholine alpha3beta4 and alpha4beta2 receptors. J Neurosci. 2000;20:529-541. (Pubitemid 30225555)
32. Valera S, Ballivet M, Bertrand D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A. 1992;89:9949-9953.
33. Kindler CH, Verotta D, Gray AT, Gropper MA, Yost CS. Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium. Anesthesiology. 2000;92:821-832. (Pubitemid 30130185)
34. Cardoso RA, Brozowski SJ, Chavez-Noriega LE, Harpold M, Valenzuela CF, Harris RA. Effects of ethanol on recombinant human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther. 1999;289:774-780. (Pubitemid 29191231)
35. 2+ on wild and mutant neuronal alpha7 nicotinic receptors. Proc Natl Acad Sci U S A. 1998;95:10246-10250.